These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 31868956)
1. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer. Hou J; Guo C; Lyu G Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050 [TBL] [Abstract][Full Text] [Related]
3. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364 [TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients. Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849 [TBL] [Abstract][Full Text] [Related]
5. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer. Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259 [TBL] [Abstract][Full Text] [Related]
6. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer. Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836 [TBL] [Abstract][Full Text] [Related]
7. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy. Lu G; Lu Z; Li C; Huang X; Luo Q Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560 [TBL] [Abstract][Full Text] [Related]
8. Associations between the Epithelial-Mesenchymal Transition Phenotypes of Circulating Tumor Cells and the Clinicopathological Features of Patients with Colorectal Cancer. Wu F; Zhu J; Mao Y; Li X; Hu B; Zhang D Dis Markers; 2017; 2017():9474532. PubMed ID: 29430076 [TBL] [Abstract][Full Text] [Related]
9. Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial-mesenchymal transition. Yang J; Ma J; Jin Y; Cheng S; Huang S; Zhang N; Wang Y Sci Rep; 2021 Mar; 11(1):6540. PubMed ID: 33753862 [TBL] [Abstract][Full Text] [Related]
10. Clinical significance of circulating tumour cells and tumour marker detection in the chemotherapeutic evaluation of advanced colorectal cancer. Shen F; Zhu Y; Wang F; Cai X; Ding H; Zhou F; Wang J; Gu H; Liu C; Li Q Colorectal Dis; 2022 Jan; 24(1):68-76. PubMed ID: 34611964 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer. Chen K; Chen Z; Ou M; Wang J; Huang X; Wu Y; Zhong W; Yang J; Huang J; Huang M; Pan D Clinics (Sao Paulo); 2022; 77():100070. PubMed ID: 36087570 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma. Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal circulating tumor cells and Ki67: their mutual correlation and prognostic implications in hepatocellular carcinoma. Yang X; Ni H; Lu Z; Zhang J; Zhang Q; Ning S; Qi L; Xiang B BMC Cancer; 2023 Jan; 23(1):10. PubMed ID: 36600214 [TBL] [Abstract][Full Text] [Related]
14. PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice. Hong XC; Liang QL; Chen M; Yang HX; Huang J; Yi SL; Wang ZW; Liang HY; Zhang DY; Huang ZY Front Oncol; 2022; 12():878639. PubMed ID: 35574414 [TBL] [Abstract][Full Text] [Related]
15. Correlation analysis of the expression of mesenchymal circulating tumor cells and CD133 with the prognosis of colorectal cancer. Zhou H; Shen H; Xiang F; Yang X; Li R; Zeng Y; Liu Z Am J Transl Res; 2023; 15(5):3489-3499. PubMed ID: 37303671 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer. Yu J; Yang M; Peng T; Liu Y; Cao Y Sci Rep; 2023 Nov; 13(1):18791. PubMed ID: 37914786 [TBL] [Abstract][Full Text] [Related]
17. Associations between the cyclooxygenase-2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer. Cai J; Huang L; Huang J; Kang L; Lin H; Huang P; Zhu P; Wang J; Dong J; Wang L; Xian CJ J Cell Biochem; 2019 Apr; 120(4):4935-4941. PubMed ID: 30260024 [TBL] [Abstract][Full Text] [Related]
18. Correlation between mesenchymal circulating tumor cells and prognosis of urologic malignancies: a single-center retrospective analysis. Wang L; Ding D Am J Transl Res; 2023; 15(1):502-510. PubMed ID: 36777844 [TBL] [Abstract][Full Text] [Related]
19. Biology and significance of circulating and disseminated tumour cells in colorectal cancer. Steinert G; Schölch S; Koch M; Weitz J Langenbecks Arch Surg; 2012 Apr; 397(4):535-42. PubMed ID: 22350614 [TBL] [Abstract][Full Text] [Related]
20. Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer. Chai J; Liu X; Hu X; Wang C Pathol Oncol Res; 2023; 29():1611224. PubMed ID: 37465316 [No Abstract] [Full Text] [Related] [Next] [New Search]